Low-dose baclofen therapy raised plasma insulin-like growth factor-1 concentrations, but not into the normal range in a predictable and sustained manner in men with chronic spinal cord injury

Journal of Spinal Cord Medicine

Volumn 36, Issue 5, 2013, Pages 476-482

  Bauman, William A ^a,b   La Fountaine, Michael F ^a,c   Cirnigliaro, Christopher M ^a   Kirshblum, Steven C ^d,e   Spungen, Ann M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SETON HALL UNIVERSITY   (United States)

^d KESSLER INSTITUTE FOR REHABILITATION   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Baclofen; Gamma aminobutyric acid; Insulin like growth factor 1; Paraplegia; Spasticity; Spinal cord injuries; Testosterone; Tetraplegia

Indexed keywords

ALBUMIN; BACLOFEN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; OPEN STUDY; PARAPLEGIA; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SELF CONCEPT; SPASTICITY; SPINAL CORD INJURY; TREATMENT DURATION; WEAKNESS; XEROSTOMIA;

ADULT; BACLOFEN; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PARAPLEGIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUADRIPLEGIA; REFERENCE VALUES; SPINAL CORD INJURIES; TESTOSTERONE;

EID: 84883388204     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772312Y.0000000061     Document Type: Article

References (37)

1. Hill DR, Bowery NG. 3H-baclofen and 3H-GABA bind to bicuculline- insensitive GABA B sites in rat brain. Nature 1981;290(5802):149-52. (Pubitemid 11149692)
2. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol 1985;17(2):107-16. (Pubitemid 15170430)
3. Volpi R, Scaglioni A, Marcato A, Caffarra P, Rossi G, Caffarri G, et al. Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1991;3(4):259-64.
4. Volpi R, Gerra G, Vourna S, Vescovi PP, Maestri D, Chiodera P, Coiro V. Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in heroin addicts. Life Sci 1992;51(4):247-51.
5. Coiro V, Capretti L, Bianconi L, Castelli A, Cerri L, Roberti G, et al. Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men. Horm Metab Res 1991;23(12):600-4.
6. Monteleone P, Maj M, Iovino M, Steardo L. Evidence for a sex difference in the basal growth hormone response to GABAergic stimulation in humans. Acta Endocrinol (Copenh) 1988;119(3):353-7.
7. Monteleone P, Maj M, Iovino M, Forziati D, Veltro F, Steardo L. Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia. Psychiatry Res 1988;26(1):1-9.
8. Koulu M, Lammintausta R, Dahlstrom S. Stimulatory effect of acute baclofen administration on human growth hormone secretion. J Clin Endocrinol Metab 1979;48(6):1038-40. (Pubitemid 9190859)
9. Chiodera P, Volpi R, Coiro V, Barilli L, Rossi G, Roti E. Naloxone does not alter the effect of gamma aminobutyric acid derivative, baclofen, on GH release in man. J Endocrinol Invest 1983;6(5):381-4. (Pubitemid 14202572)
10. Murakami Y, Kato Y, Kabayama Y, Tojo K, Inoue T, Imura H. Involvement of growth hormone-releasing factor in growth hormone secretion induced by gamma-aminobutyric acid in conscious rats. Endocrinology 1985;117(2):787-9. (Pubitemid 15237903)
11. Daughaday WH. A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity. Perspect Biol Med 1989;32(2):194-211.
12. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983;113(1):297-305. (Pubitemid 13045152)
13. Florini JR, Prinz PN, Vitiello MV, Hintz RL. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 1985;40(1):2-7. (Pubitemid 15158653)
14. Bauman WA, Spungen AM, Flanagan S, Zhong YG, Alexander LR, Tsitouras PD. Blunted growth hormone response to intravenous arginine in subjects with a spinal cord injury. Horm Metab Res 1994;26(3):152-6. (Pubitemid 24131298)
15. Tsitouras PD, Zhong YG, Spungen AM, Bauman WA. Serum testosterone and growth hormone/insulin-like growth factor-I in adults with spinal cord injury. Horm Metab Res 1995;27(6):287-92.
16. Shetty KR, Sutton CH, Mattson DE, Rudman D. Hyposomatomedinemia in quadriplegic men. Am J Med Sci 1993;305(2):95-100. (Pubitemid 23046463)
17. Bauman WA, La Fountaine MF, Spungen AM. Age-related prevalence of hypogonadism in men with spinal cord injury. J Spinal Cord Med 2013, published online, DOI: 10.1179/2045772313Y.0000000122.
18. Wang YH, Huang TS, Lien IN. Hormone changes in men with spinal cord injuries. Am J Phys Med Rehabil 1992;71(6):328-32.
19. Huang TS, Wang YH, Chiang HS, Lien YN. Pituitary-testicular and pituitary-thyroid axes in spinal cord-injured males. Metabolism 1993;42(4):516-21.
20. Spungen AM, Bauman WA, Wang J, Pierson RN, Jr. Measurement of body fat in individuals with tetraplegia: a comparison of eight clinical methods. Paraplegia 1995;33(7):402-8.
21. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306(19):1136-40. (Pubitemid 12161336)
22. Naftchi NE, Viau AT, Sell GH, Lowman EW. Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil 1980;61(3):139-42. (Pubitemid 10130259)
23. Sedlock DA, Laventure SJ. Body composition and resting energy expenditure in long term spinal cord injury. Paraplegia 1990;28(7):448-54. (Pubitemid 20301751)
24. Buchholz AC, McGillivray CF, Pencharz PB. Differences in resting metabolic rate between paraplegic and able-bodied subjects are explained by differences in body composition. Am J Clin Nutr 2003;77(2):371-8. (Pubitemid 36133379)
25. Spungen AM, Bauman WA, Wang J, Pierson RN, Jr. The relationship between total body potassium and resting energy expenditure in individuals with paraplegia. Arch Phys Med Rehabil 1993;74(9):965-8. (Pubitemid 23275107)
26. Bauman WA, Spungen AM. Body composition in aging: adverse changes in able-bodied persons and in those with spinal cord injury. Top Spinal Cord Inj Rehabil 2001;6(3):22-36. (Pubitemid 32105174)
27. Kocina P. Body composition of spinal cord injured adults. Sports Med 1997;23(1):48-60. (Pubitemid 27060899)
28. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84(10):3666-72. (Pubitemid 30645223)
29. Bauman WA, Kirshblum SC, Morrison NG, Cirnigliaro CM, Zhang RL, Spungen AM. Effect of low-dose baclofen administration on plasma insulin-like growth factor-I in persons with spinal cord injury. J Clin Pharmacol 2006;46(4):476-82.
30. Amikishieva AV. Testosterone and behavior: involvement of the hormone in psychotropic effects of baclofen. Bull Exp Biol Med 2007;143(2):259-63. (Pubitemid 47225387)
31. Oppenheimer JH, Silva E, Schwartz HL, Surks MI. Stimulation of hepatic mitochondrial alpha-glycerophosphate dehydrogenase and malic enzyme by L-triiodothyronine. Characteristics of the response with specific nuclear thyroid hormone binding sites fully saturated. J Clin Invest 1977;59(3):517-27. (Pubitemid 8061223)
32. Goldspink G. Age-related loss of muscle mass and strength. J Aging Res 2012;1-11.
33. Spungen AM, Adkins RH, Stewart CA, Wang J, Pierson RN, Jr, Waters RL, et al. Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol 2003;95:2398-407. (Pubitemid 37444985)
34. Spungen AM, Wang J, Pierson RN, Jr, Bauman WA. Soft tissue body composition differences in monozygotic twins discordant for spinal cord injury. J Appl Physiol 2000;88:1310-5. (Pubitemid 30217431)
35. Bauman WA, Zhang RL, Spungen AM. Provocative stimulation of growth hormone: a monozygotic twin study discordant for spinal cord injury. J Spinal Cord Med 2007;30(5):467-72. (Pubitemid 350247166)
36. Qin W, Bauman WA, Cardozo C. Bone and muscle loss after spinal cord injury: organ interactions. Ann NY Acad Sci 2010;1211:66-84.
37. Lang TF. The bone-muscle relationship in men and women. J Osteoporos 2011:70235.